Specific interaction of murine colony-stimulating factor with mononuclear phagocytic cells - PubMed (original) (raw)
Specific interaction of murine colony-stimulating factor with mononuclear phagocytic cells
L J Guilbert et al. J Cell Biol. 1980 Apr.
Abstract
L-cell colony-stimulating factor (CSF) is identical to macrophage growth factor and stimulates macrophage proliferation (Stanley et al., 1976, J. Exp. Med. 143: 631-647). The nature of the interaction of iodinated L-cell CSF (125I-CSF) with murine peritoneal exudate macrophages was studied. On incubation with 10 pM 125I-CSF at 0 degrees C, cellular binding of 125I-CSF reaches a stable maximum within 15 h. This is in contrast to the association behavior at higher temperatures. At 37 degrees C, cell-associated 125I-CSF levels reach, within 45 min, an unstable maximum which is up to 10-fold less than that occurring under the same conditions at 0 degrees C. At 0 degrees C, binding is saturated (approximately 5 X 10(4) sites/cell) at CSF concentrations of 1 nM. A comparison of binding and competition experiments indicates that iodinated L-cell CSF binds as effectively as L-cell CSF and that human urinary CSF and L-cell CSF equipotently compete for 125I-CSF binding. Specificity of the CSF-binding site is demonstrated by the failure of other known growth factors and hormones to compete for 125I-CSF binding. These studies and other findings suggest that 125I-CSF binding is restricted to macrophages and their precursors and to macrophage cell lines and that the binding site(s) is the receptor mediating the biological action of this CSF.
Similar articles
- The specific binding activities of human urinary radioiodinated colony-stimulating factor-1 to various human tissue cells.
Gao GA, Zhu DX, Tao X, Zheng J, Scharfman A, Lamblin G, Shing YW, Han KK. Gao GA, et al. Int J Biochem. 1989;21(4):391-9. doi: 10.1016/0020-711x(89)90363-7. Int J Biochem. 1989. PMID: 2526035 - Tumor-promoting phorbol esters inhibit the binding of colony-stimulating factor (CSF-1) to murine peritoneal exudate macrophages.
Chen BD, Lin HS, Hsu S. Chen BD, et al. J Cell Physiol. 1983 Aug;116(2):207-12. doi: 10.1002/jcp.1041160212. J Cell Physiol. 1983. PMID: 6306017 - The interaction of 125I-colony-stimulating factor-1 with bone marrow-derived macrophages.
Guilbert LJ, Stanley ER. Guilbert LJ, et al. J Biol Chem. 1986 Mar 25;261(9):4024-32. J Biol Chem. 1986. PMID: 3485098 - Modulation of colony-stimulating factor-1 receptors on macrophages by tumor necrosis factor.
Shieh JH, Peterson RH, Warren DJ, Moore MA. Shieh JH, et al. J Immunol. 1989 Oct 15;143(8):2534-9. J Immunol. 1989. PMID: 2551961 - Binding, internalization and degradation of colony-stimulating factor by peritoneal exudate macrophages.
Chen BD, Hsu S, Lin HS. Chen BD, et al. Biochim Biophys Acta. 1982 Dec 30;721(4):366-73. doi: 10.1016/0167-4889(82)90091-x. Biochim Biophys Acta. 1982. PMID: 6984345
Cited by
- CSF1R antagonism results in increased supraspinal infiltration in EAE.
Wang M, Caryotakis SE, Smith GG, Nguyen AV, Pleasure DE, Soulika AM. Wang M, et al. J Neuroinflammation. 2024 Apr 20;21(1):103. doi: 10.1186/s12974-024-03063-1. J Neuroinflammation. 2024. PMID: 38643194 Free PMC article. - Inhibition of CSF1R and KIT With Pexidartinib Reduces Inflammatory Signaling and Cell Viability in Endometriosis.
Dunn TN, Cope DI, Tang S, Sirupangi T, Parks SE, Liao Z, Yuan F, Creighton CJ, Masand RP, Alpuing Radilla L, Guan X, Detti L, Monsivais D, Matzuk MM. Dunn TN, et al. Endocrinology. 2024 Feb 20;165(4):bqae003. doi: 10.1210/endocr/bqae003. Endocrinology. 2024. PMID: 38227801 - Macrophage colony-stimulating factor ameliorates myocardial injury in mice after myocardial infarction by regulating cardiac macrophages through the P2X7R/NLRP3/IL-1β signal pathway.
Zhang SJ, Huang CX, Zhao QY, Huang H, Zhang J. Zhang SJ, et al. Heliyon. 2023 Oct 10;9(10):e20805. doi: 10.1016/j.heliyon.2023.e20805. eCollection 2023 Oct. Heliyon. 2023. PMID: 37860548 Free PMC article. - Airway soluble CSF1R predicts progression in patients with idiopathic pulmonary fibrosis.
Oldham JM, Johnson KW, Albers GJ, Calamita E, Mah J, Ghai P, Hewitt RJ, Maher TM, Molyneaux PL, Huang M, Byrne AJ. Oldham JM, et al. ERJ Open Res. 2023 Jul 17;9(4):00690-2022. doi: 10.1183/23120541.00690-2022. eCollection 2023 Jul. ERJ Open Res. 2023. PMID: 37465557 Free PMC article. - Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021.
Wu Q, Qian W, Sun X, Jiang S. Wu Q, et al. J Hematol Oncol. 2022 Oct 8;15(1):143. doi: 10.1186/s13045-022-01362-9. J Hematol Oncol. 2022. PMID: 36209184 Free PMC article. Review.
References
- J Cell Physiol. 1965 Dec;66(3):319-24 - PubMed
- Aust J Exp Biol Med Sci. 1966 Jun;44(3):287-99 - PubMed
- J Cell Physiol. 1969 Dec;74(3):223-34 - PubMed
- Exp Cell Res. 1970 Apr;60(1):61-77 - PubMed
- J Cell Physiol. 1970 Aug;76(1):89-99 - PubMed